Adjuvant versus salvage post-prostatectomy radiation therapy: A critical review of the evidence

Journal of Urology

Volumn 190, Issue 2, 2013, Pages 450-451

  D'Amico, Anthony V ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADJUVANT EXTERNAL BEAM RADIATION THERAPY; ADJUVANT THERAPY; CANCER RISK; CANCER SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; GLEASON SCORE; HUMAN; MALE; NOTE; ONCOLOGY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SALVAGE THERAPY;

EID: 84880044782     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2013.05.028     Document Type: Editorial

References (4)

1. I.M. Thompson, C.M. Tangen, J. Paradelo Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial J Urol 181 2009 956
2. M. Bolla, H. van Poppel, B. Tombal European Organisation for Research and Treatment of Cancer, Radiation Oncology and Genito-Urinary Groups Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911) Lancet 380 2012 2018
3. Wiegel T, Bottke D, Bartkowiak D, et al. Phase III results of adjuvant radiotherapy (RT) versus wait-and-see (WS) in patients with pT3 prostate cancer following radical prostatectomy (RP)(ARO 96-02/AUO AP 09/95): ten years follow-up (abstract 4). Presented at ASCO 2013 Genitourinary Cancers Symposium, Orlando, Florida, February 14-16, 2013.
4. A.V. D'Amico, M.H. Chen, L. Sun Adjuvant versus salvage radiation therapy for prostate cancer and the risk of death BJU Int 106 2010 1618